These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22677638)

  • 21. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
    Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis.
    Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F
    Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
    Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
    Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Triple-TEN" in the treatment of acute ocular complications from toxic epidermal necrolysis.
    Tomlins PJ; Parulekar MV; Rauz S
    Cornea; 2013 Mar; 32(3):365-9. PubMed ID: 22677638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular surface inflammation mediated by innate immunity.
    Ueta M; Kinoshita S
    Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burn unit treatment of acute, severe exfoliating disorders.
    Halebian PH; Shires GT
    Annu Rev Med; 1989; 40():137-47. PubMed ID: 2658743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage.
    Sotozono C; Ueta M; Yokoi N
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES80-DES86. PubMed ID: 30481810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.
    Chang VS; Chodosh J; Papaliodis GN
    Semin Ophthalmol; 2016; 31(1-2):178-87. PubMed ID: 26959145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know?
    Tartarone A; Lerose R
    Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ciralsky JB; Sippel KC; Gregory DG
    Curr Opin Ophthalmol; 2013 Jul; 24(4):321-8. PubMed ID: 23680755
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.